1. Home
  2. LEGT vs TERN Comparison

LEGT vs TERN Comparison

Compare LEGT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGT
  • TERN
  • Stock Information
  • Founded
  • LEGT 2023
  • TERN 2017
  • Country
  • LEGT United States
  • TERN United States
  • Employees
  • LEGT N/A
  • TERN N/A
  • Industry
  • LEGT
  • TERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEGT
  • TERN Health Care
  • Exchange
  • LEGT Nasdaq
  • TERN Nasdaq
  • Market Cap
  • LEGT 274.3M
  • TERN 321.4M
  • IPO Year
  • LEGT 2024
  • TERN 2021
  • Fundamental
  • Price
  • LEGT N/A
  • TERN $4.32
  • Analyst Decision
  • LEGT
  • TERN Buy
  • Analyst Count
  • LEGT 0
  • TERN 5
  • Target Price
  • LEGT N/A
  • TERN $15.63
  • AVG Volume (30 Days)
  • LEGT 16.6K
  • TERN 895.2K
  • Earning Date
  • LEGT 01-01-0001
  • TERN 08-04-2025
  • Dividend Yield
  • LEGT N/A
  • TERN N/A
  • EPS Growth
  • LEGT N/A
  • TERN N/A
  • EPS
  • LEGT 0.29
  • TERN N/A
  • Revenue
  • LEGT N/A
  • TERN N/A
  • Revenue This Year
  • LEGT N/A
  • TERN N/A
  • Revenue Next Year
  • LEGT N/A
  • TERN N/A
  • P/E Ratio
  • LEGT $0.94
  • TERN N/A
  • Revenue Growth
  • LEGT N/A
  • TERN N/A
  • 52 Week Low
  • LEGT $10.10
  • TERN $1.87
  • 52 Week High
  • LEGT $10.86
  • TERN $11.40
  • Technical
  • Relative Strength Index (RSI)
  • LEGT N/A
  • TERN 65.96
  • Support Level
  • LEGT N/A
  • TERN $3.67
  • Resistance Level
  • LEGT N/A
  • TERN $4.39
  • Average True Range (ATR)
  • LEGT 0.00
  • TERN 0.31
  • MACD
  • LEGT 0.00
  • TERN 0.01
  • Stochastic Oscillator
  • LEGT 0.00
  • TERN 91.67

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Share on Social Networks: